A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY

PHASE2CompletedINTERVENTIONAL
Enrollment

151

Participants

Timeline

Start Date

January 6, 2021

Primary Completion Date

November 17, 2021

Study Completion Date

November 17, 2021

Conditions
DiabetesObesity
Interventions
DRUG

PF-06882961

PF-68882961 will be provided as tablets twice a day (BID)

OTHER

Placebo

Placebo comparator will be provided as tablets twice daily for 12 weeks

Trial Locations (38)

13760

Meridian Clinical Research, LLC DBA Regional Clinical Research, Endwell

15009

Heritage Valley Medical Group, Inc., Beaver

20011

Emerson Clinical Research Institute, Washington D.C.

20110

Manassas Clinical Research Center, Manassas

27103

PMG Research of Winston-Salem, LLC, Winston-Salem

27518

PMG Research of Raleigh, LLC d/b/a PMG Research of Cary, Cary

27804

PMG Research of Rocky Mount, LLC - Investigational Product and Mail delivery, Rocky Mount

PMG Research of Rocky Mount, LLC - Patient Visits, Rocky Mount

28150

Carolina Research Center, Inc., Shelby

28209

PMG Research of Charlotte, LLC, Charlotte

28601

PMG Research of Hickory, LLC, Hickory

29485

Palmetto Clinical Research, Summerville

Palmetto Primary Care Physicians (physicals only), Summerville

32256

Clinical Neuroscience Solutions, Inc., Jacksonville

33024

Pines Care Research Center, LLC, Pembroke Pines

33142

Acevedo Clinical Research Associates, Miami

33756

Innovative Research of West Florida, Inc., Clearwater

38119

Clinical Neuroscience Solutions, Inc., Memphis

42303

Research Integrity, LLC, Owensboro

45219

Sterling Research Group, Ltd., Cincinnati

51106

Meridian Clinical Research, LLC, Sioux City

63005

Clinical Research Professionals, Chesterfield

70006

Nola Care LLC, Metairie

72143

Unity Health - Searcy Medical Center, Searcy

75230

Dallas Diabetes Research Center, Dallas

77074

Juno Research, LLC, Houston

78231

Consano Clinical Research, LLC, Shavano Park

83646

Solaris Clinical Research, Meridian

84010

Bountiful Internal Medicine, Bountiful

Progressive Clinical Research, Bountiful

Wade Family Medicine, Bountiful

85053

Arizona Research Center, Phoenix

91730

Rancho Cucamonga Clinical Research, Rancho Cucamonga

91763

Catalina Research Institute, LLC, Montclair

92262

Desert Oasis Healthcare Medical Group, Palm Springs

92780

University Clinical Investigators, Inc., Tustin

94598

Diablo Clinical Research, Inc., Walnut Creek

92123-1881

California Research Foundation, San Diego

Sponsors

Lead Sponsor

All Listed Sponsors
lead

Pfizer

INDUSTRY

NCT04617275 - A 12-WEEK TITRATE STUDY TO EVALUATE SAFETY, TOLERABILITY AND PHARMACODYNAMICS OF PF-06882961 IN ADULTS WITH TYPE 2 DIABETES MELLITUS AND IN NON-DIABETIC ADULTS WITH OBESITY | Biotech Hunter | Biotech Hunter